The purpose of this study was to validate the diagnosis of periprosthetic joint infection (PJI) in the Danish Hip Arthroplasty Register (DHR).
Periprosthetic joint infection (PJI) is a serious complication of total hip arthroplasty (THA).
Over the years, a number of clinical studies have attempted to assess the risk factors for PJI but these have often been hampered in their conclusions by short follow-up, loss to follow-up and/ or a limited number of patients. 1 To overcome these problems, national registers for hip arthroplasty have been established and appear to give more reliable results. 2, 3 One of these is the Danish Hip Arthroplasty Register (DHR). 4 Since 1995, all Danish orthopaedic departments which undertake primary and revision arthroplasty have been mandated to submit their data prospectively. Consequently, it is possible to undertake population-based studies with longterm follow-up. The organisation of the Danish healthcare system also makes it possible to link these data with those of other national databases. 5 To use registers for decision making, both in the healthcare system and for research, it is essential to have valid data and registration that is complete and unbiased. The DHR has previously been validated for 'diagnosis' in patients undergoing primary THA and for 'post-operative complications ', 6 with the completeness of registration of both primary and revision surgery evaluated annually. 7 As the data about revision arthroplasty for PJI have not yet been validated, the quality of the diagnosis 'PJI' reported to the DHR is still unknown.
The aim of this study was to validate the diagnosis of PJI reported to the DHR for first-time revisions by testing it against a benchmark. A secondary aim was to investigate whether the accuracy of the diagnosis 'PJI' in the DHR could be further improved by linking it with data from existing microbiology databases.
Patients and Methods
The study was approved by the National Board of Health (journal number 3-3013-303/1/), the steering committee of the DHR and the Danish Data Protection Agency (journal number 2008-58-0035).
Setting. This population-based cohort study was conducted using the unique civil registration number which is assigned at birth or on immigration to all Danish citizens (5.6 million inhabitants).
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The civil registration number is recorded for all healthcare contacts, including emergency and hospital admissions, and outpatient clinic visits provided by the National Health Service. As the civil registration number is unique and unchangeable, it allows for unambiguous linkage between registers.
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Data sources. DHR: The DHR was established in 1995 to examine the epidemiology and improve the quality of primary and revision THA in Denmark. 4 Registration is compulsory for all orthopaedic departments (both private and public), and is undertaken by the operating surgeon immediately after surgery.
The indication for revision is recorded as aseptic loosening of the femur and/or the acetabular component with or without osteolysis; wear of the polyethylene without loosening; deep infection; fracture of the femur; dislocation of the hip; pain; osteolysis and other less frequent causes. 9 The extent of revision is reported as removal or exchange of any part of the prosthesis. However, debridement without removal of any part of the prosthesis is also classified as revision, as it may be carried out for PJI.
According to the DHR annual report of 2014, the completeness of data is 96.1% for primary THA and 94.3% for revisions when compared with data from the National Register of Patients. 10 Microbiology databases: all orthopaedic departments in Denmark refer intra-operative samples to the nearest department of clinical microbiology in the same health region. These keep all requests and reports in the electronic laboratory information system using the civil registration number as a patient identifier. All the departments which serve the hospitals in which revisions were performed provided data on intra-operative samples and aspirates.
Medical records: these were either obtained from the hospital in which the revision surgery was undertaken or from the e-journal database maintained by the Ministry of Public Health jointly with the Danish health regions. Data sources used for the benchmark. In addition to the above mentioned data sources, the following data sources were used to develop an algorithm which we used as the benchmark for PJI: prescription database, clinical biochemistry databases and data from the National Register of Patients. This algorithm has already been published.
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Methods. The DHR was searched for all primary THAs carried out in hospitals in Jutland and Funen between 1 January 2005 and 31 December 2012. These formed the study population. Data about intra-operative cultures were only accessible in a standard file format from Jutland and Funen (3.1 million inhabitants), which is why primary THAs performed in other regions were excluded from the study. If a patient had undergone primary THA in Jutland or Funen and revision surgery at a hospital in another Danish health region, the information on intra-operative culture was obtained from the laboratory information system for that individual patient.
Patients were excluded from the study population if they had been registered incorrectly e.g., incorrect civil registration number, more than one registration on the same operation side, or missing information on the date or side of operation (Fig. 1) .
Using the civil registration number and the reported side of the operation, the primary THA could be directly linked to the first-time revision (Fig. 1 ). All revisions after the first-time revision were excluded. Therefore, only the first stage procedure was included in the case of a two-stage revision. As a result, all intra-operative cultures were taken from a one-stage procedure or the first part of a two-stage procedure.
The diagnosis of PJI reported to the DHR was validated against a benchmark by calculating its specificity, sensitivity, positive predictive value (PPV) and negative predictive value (NPV). As a benchmark, we used an algorithm which incorporated data from microbiology databases (including intra-operative cultures and aspirates), a prescription database (including antibiotic treatment before revision), clinical biochemistry databases (including C-reactive protein, CRP), data from the National Register of Patients, the DHR and findings obtained from the medical records (description of a sinus track or purulence in the joint).
In order to investigate whether the accuracy of the diagnosis of PJI in the DHR could be further improved by linkage with existing microbiology databases, the calculation was done for DHR alone and DHR combined with data from microbiology databases.
In the analysis of DHR linked to microbiology databases, PJI was defined as three or more intra-operative samples with the same virulent or opportunistic micro-organism, or PJI registered in DHR as the indication for revision.
Non-infected revision was defined as all of five or more negative intra-operative samples on culture, or PJI not being the indication for revision in DHR. Analysis. For validation of the diagnosis of PJI reported to the DHR, four different measurements were used:
Sensitivity was defined as the proportion of revisions reported to the DHR because of PJI, which were correctly classified according to the benchmark. Sensitivity was calculated by the formula (true positives × 100)/(true positives + false negatives). The numerator was the number of true PJI reported to the DHR. The denominator was the total number of PJI according to the benchmark (true positives + false negatives).
Specificity was defined as the number of non-infected revisions reported to the DHR which were correctly classified as not infected according to the benchmark. Specificity was calculated by the formula (true negatives × 100)/(true negatives + false positives). The numerator was the number of true non-infected revisions reported to the DHR (true negative): the denominator was the total number of noninfected revisions according to the benchmark (true negatives + false positives).
PPV was defined as the probability that a revision reported to the DHR as 'PJI' was actually infected according to the benchmark. PPV was calculated by the formula (true positives × 100)/(true positives + false positives). The numerator was the number of true PJI reported to the DHR (true positives): the denominator was the total number of PJI reported to the DHR (true positives + false positives).
Negative predictive value was defined as the probability that a revision reported to the DHR as not infected was not infected according to the benchmark. NPV was calculated by the formula (true negatives × 100)/(false negatives + true negatives). The numerator was the number of true noninfected revisions reported to the DHR (true negatives): the denominator was the total number of revisions reported as not infected in the DHR (false negatives + true negatives).
95% confidence intervals were calculated for the estimates of sensitivity, specificity, PPV and NPV.
All false positives and false negatives were subsequently analysed. Stratification. Any registered cause of revision in the DHR was analysed and stratified into early, delayed or late. Early revision was defined as being within three months of primary THA; delayed, more than three but less than 24 months after primary THA, and late as more than 24 months after primary THA. 
Results
Of 37 826 primary THAs identified from the DHR, 1408 had been revised for any cause. An error in registration (incorrect civil registration number, missing information on operation side or date) excluded 26 ( Fig. 1) leaving 1382 revisions.
There were 748 women (54%) and 634 men (46%) with a mean age at the time of revision of 69 years (22 to 96). Of these 232 (116 men and 116 women) were reported as having been carried out because of PJI.
The diagnosis of PJI had an overall sensitivity of 67%, a specificity of 95%, a PPV of 77% and an NPV of 92% (Table I) . Stratification by time to revision, year of reporting and gender did not reveal any significant differences (Table I) .
If pus was present or the CRP level elevated preoperatively, the sensitivity, specificity, PPV and NPV were substantially higher (Table I) . Sensitivity was also higher if the micro-organism was virulent, rather than opportunistic.
Altogether 53 cases were registered as false positives according to the algorithm, a minimum of five intra-operative cultures had been taken during surgery in 49, all of which were sterile. In the other four, neither intra-operative cultures nor aspiration had been taken. In 11 of the false positives, we found a description of joint purulence in the medical record, all of which had negative intra-operative cultures and there was no record of any of pre-operative antibiotics having been taken within 14 days before revision. None of the other medical records had descriptions to justify the diagnosis of PJI.
In total, 88 cases were registered as false negatives. In 87 of these false negative cases, four or more intra-operative cultures had been taken during surgery, and for 76 of those revisions, three or more of the cultures were with growth of micro-organism. In the other 11, the CRP was elevated before revision and two intra-operative cultures or one culture and one aspiration were positive.
When combined with microbiology databases and using the definition for PJI and non-infected revision described, 62 patients were re-classified from false negative to true positive and 49 were re-classified from false positive to true negative, which increased the sensitivity to 90%, the specificity to 100%, PPV to 98% and NPV to 98% (Table II) .
Discussion
This study showed that the DHR captured only 67% of the hips revised for PJI (sensitivity). Moreover, of those reported as PJI, 23% were misclassified (PPV) according to our benchmark. However, when combined with data from the microbiology databases, nearly all non-infected hips were classified correctly i.e., 100% specificity, with the sensitivity increased to 90% and PPV and NPV to 98%.
The 67% sensitivity for PJI is consistent with findings from other studies of arthroplasty registers.
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The reason for not capturing all PJI in the DHR may be related to the registration process. The surgeon reports to the registry immediately after surgery when the results of cultures taken during surgery are not available. If the cultures turn out to be positive, there is no direct communication to the register, and the diagnosis is unlikely to be revised. This could explain why 62 cases were re-classified to PJI when the DHR was combined with the microbiology databases. We also found that if the CRP was elevated and/or pus was present at the time of surgery, sensitivity and PPV were higher than when these findings were absent.
The reason why revisions in which virulent micro-organisms were isolated were more often correctly identified as PJI than revisions for opportunistic micro-organisms may be that the former are more likely to produce pus and an elevated CRP. It is therefore more likely that the surgeon will diagnose PJI at the time of surgery. Surprisingly, we only confirmed 77% (PPV) of PJI registered in the DHR, however, our analysis of the falsepositive PJI revisions, which included an audit of the medical records, revealed no factors which confirmed these THAs as infected. We therefore believe that the algorithm which we used as a benchmark correctly classified these 53 false-positive cases as 'non-infected'. A key strength to this study was the high coverage and completeness of the records in the DHR. Moreover, the ability to link multiple data sources, using the unique civil registration number, allowed us to test the data in the DHR against a benchmark which included microbiological data, whether or not antibiotics had been given before revision, if the CRP had been elevated and whether there was a sinus track or pus in the joint. Consequently, we could address all the important factors needed to validate the DHR. We have also shown the importance of combining databases.
One notable limitation was that pertinent information was missing for some patients, e.g., revision performed without intra-operative cultures having being taken, or without the CRP level being measured before revision. Information on antibiotic treatment before operation and pre-operative prophylaxis may also have been recorded inconsistently.
The DHR was validated for primary procedure data and completeness in 2004. 6 The authors stated that data on post-operative complications, such as PJI, should be used with caution.
The diagnosis of PJI in the Swedish Hip Arthroplasty Register has recently been validated. Their findings were very similar to ours with a moderate sensitivity of 60%, a PPV of 76% and a high specificity of 99% and NPV of 99%. 15 However, they were not able to link their registry data to microbiology databases. Studies from Finland have also reported that PJI is underestimated in the Finnish Arthroplasty Register. 13, 14 Other national registers are yet to validate the diagnosis of PJI. However, validation of the Norwegian Arthroplasty Register, the Dutch Arthroplasty Register and the National Joint Registry for England, Wales and Northern Ireland has shown that the rate of revision is underestimated. This also affects the estimated incidence of PJI. [16] [17] [18] DHR and other national registers have already contributed to the identification of risk factors such as male gender; comorbidity; prolonged surgery and patients operated on for atraumatic avascular necrosis of the femoral head. 2 Other studies using registry data have shown that there is an increased risk of revision owing to PJI. 3 However, researchers should be cautious about using data on PJI from a national register because of the moderate sensitivity and PPV, especially when absolute estimates of the incidence of PJI and of risk factors for PJI are studied. Estimates of relative risk may not be similarly affected if the underestimate is without bias for the risk factors studied, such as gender.
This study highlights the problem of using arthroplasty registers for monitoring and studying PJI. However, discarding them as a tool for PJI research would be imprudent, as they offer a high volume of data which are not otherwise obtainable, but they must be used appropriately. The diagnosis reported to the register is that of the surgeon at the time of surgery. However, this information is in many cases insufficient to make a definitive diagnosis of PJI. Consequently, it can be difficult to rely on the surgeon's decision and subjective opinion at the time of surgery. Thus, we believe this approach to be outdated. A solution to the problem might be to postpone reporting until more details are available and, most importantly, until after the definitive culture reports. However, this delay may reduce the completeness of reporting, which has otherwise been very high for several registers. As we have shown, another solution may be to link arthroplasty registers with microbiological databases and to use a PJI algorithm which has gained international acceptance. Currently, linking databases is technically feasible, but the process is time consuming and laborious, and needs to be more efficient in order to improve the validity of registers.
Only two thirds of revisions for PJI were captured in the DHR, and only 77% of the diagnoses of PJI reported to the register could be confirmed. However, the validity of the diagnosis of PJI was remarkably improved by combining the register with microbiology databases.
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